Neutropenia Secondary to AML Treatment
Neutropenia Secondary to AML Treatment: Neutropenia is a severe reduction in neutrophil count, a type of white blood cell essential for fighting infections. In patients
Neutropenia Secondary to AML Treatment: Neutropenia is a severe reduction in neutrophil count, a type of white blood cell essential for fighting infections. In patients
Acute myeloid leukemia (AML) is an aggressive form of blood cancer characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by clonal proliferation of myeloid precursors. Among the various subtypes, CD33-positive AML represents a critical